374 related articles for article (PubMed ID: 21723199)
21. Nitrous oxide revisited: evidence for potent antihyperalgesic properties.
Richebé P; Rivat C; Creton C; Laulin JP; Maurette P; Lemaire M; Simonnet G
Anesthesiology; 2005 Oct; 103(4):845-54. PubMed ID: 16192778
[TBL] [Abstract][Full Text] [Related]
22. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
[TBL] [Abstract][Full Text] [Related]
23. Secondary heat, but not mechanical, hyperalgesia induced by subcutaneous injection of bee venom in the conscious rat: effect of systemic MK-801, a non-competitive NMDA receptor antagonist.
Chen HS; Chen J
Eur J Pain; 2000; 4(4):389-401. PubMed ID: 11124011
[TBL] [Abstract][Full Text] [Related]
24. Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan.
França DS; Ferreira-Alves DL; Duarte ID; Ribeiro MC; Rezende RM; Bakhle YS; Francischi JN
Neuropharmacology; 2006 Jul; 51(1):37-43. PubMed ID: 16620880
[TBL] [Abstract][Full Text] [Related]
25. Effects of intravenous Injections Paederiae and Stauntonia on spontaneous pain, hyperalgesia and inflammation induced by cutaneous chemical tissue injury in the rat.
Peng XL; Gao XL; Chen J; Huang X; Chen HS
Sheng Li Xue Bao; 2003 Oct; 55(5):516-24. PubMed ID: 14566397
[TBL] [Abstract][Full Text] [Related]
26. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
27. Anti-hyperalgesic effects of intrathecally administered neuropeptide W-23, and neuropeptide B, in tests of inflammatory pain in rats.
Yamamoto T; Saito O; Shono K; Tanabe S
Brain Res; 2005 May; 1045(1-2):97-106. PubMed ID: 15910767
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the N-methyl-d-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery.
Zhang GH; Min SS; Seol GH; Lee KS; Han H; In Kim Y; Han HC
Pain; 2009 Jun; 143(3):233-237. PubMed ID: 19361925
[TBL] [Abstract][Full Text] [Related]
29. Inflammation mobilizes local resources to control hyperalgesia: the role of endogenous opioid peptides.
Alves DP; da Motta PG; Lima PP; Queiroz-Junior CM; Caliari MV; Pacheco DF; Pacheco CF; Francischi JN; Duarte ID
Pharmacology; 2012; 89(1-2):22-8. PubMed ID: 22236644
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of prior administration of magnesium on delayed hyperalgesia induced by fentanyl in rats.
Van Elstraete AC; Sitbon P; Mazoit JX; Conti M; Benhamou D
Can J Anaesth; 2006 Dec; 53(12):1180-5. PubMed ID: 17142651
[TBL] [Abstract][Full Text] [Related]
31. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
32. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy.
Qian J; Brown SD; Carlton SM
Brain Res; 1996 Apr; 715(1-2):51-62. PubMed ID: 8739622
[TBL] [Abstract][Full Text] [Related]
33. Release of endogenous opioids following transcutaneous electric nerve stimulation in an experimental model of acute inflammatory pain.
Sabino GS; Santos CM; Francischi JN; de Resende MA
J Pain; 2008 Feb; 9(2):157-63. PubMed ID: 17988952
[TBL] [Abstract][Full Text] [Related]
34. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
[TBL] [Abstract][Full Text] [Related]
35. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
[TBL] [Abstract][Full Text] [Related]
36. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
[TBL] [Abstract][Full Text] [Related]
37. Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats.
Rodrigues LL; Oliveira MC; Pelegrini-da-Silva A; de Arruda Veiga MC; Parada CA; Tambeli CH
J Pain; 2006 Dec; 7(12):929-36. PubMed ID: 17157779
[TBL] [Abstract][Full Text] [Related]
38. Peripheral mu-, kappa- and delta-opioid receptors mediate the hypoalgesic effect of celecoxib in a rat model of thermal hyperalgesia.
Correa JD; Paiva-Lima P; Rezende RM; Dos Reis WG; Ferreira-Alves DL; Bakhle YS; Francischi JN
Life Sci; 2010 Jun; 86(25-26):951-6. PubMed ID: 20451533
[TBL] [Abstract][Full Text] [Related]
39. Peripheral control of inflammatory but not neuropathic pain by endogenous cholinergic system.
Motta PG; Perez AC; Alves DP; Duarte ID
Pharmacology; 2011; 88(1-2):18-25. PubMed ID: 21720188
[TBL] [Abstract][Full Text] [Related]
40. The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain.
Lee HJ; Pogatzki-Zahn EM; Brennan TJ
J Pain; 2006 Oct; 7(10):768-77. PubMed ID: 17018337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
